Every year, more than 800,000 people worldwide die from hepatitis-B-related liver disease — a greater toll than from malaria. Efforts to curb transmission and develop drugs that eliminate the virus are picking up steam in a global effort to eradicate the disease. This Nature Outlook explores:
The development of an array of drugs that could, in the right combination, liberate millions of people from hepatitis.
How hepatitis B — often acting alongside obesity, fatty liver disease and certain gut microbiota — raises the risk of liver cancer.
The stigmatization of the condition in many parts of the world — and how patients are finding a voice to push back and demand an end to discrimination and isolation.
The effort to stop the spread of the disease from infected mothers to their newborns.
Why, despite some success stories, the global fight against hepatitis B is making uneven progress — with the lower-income parts of the world getting the short straw.
Hepatitis B is widespread in sub-Saharan Africa, but many countries lack the resources to heighten awareness and treat patients.
Why Indigenous people in Australia have such a high prevalence of hepatitis B.
Read more – access your free Nature Outlook today »作者: StephenW 时间: 2022-4-1 20:58